---
title: "Prevnar 20 (Pneumococcal 20-valent Conjugate Vaccine), all indications: Pharmacology questions"
description: "Pharmacology questions on Prevnar 20 (Pneumococcal 20-valent Conjugate Vaccine) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Components and Mechanism. Questions: Which pneumococcal serotypes does Prevnar 20 contain? What are the ingredients in a Prevnar 20 dose? How does Prevnar 20 work (mechanism of action)? 3 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/prevnar-20/pharmacology"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Prevnar 20 (Pneumococcal 20-valent Conjugate Vaccine), all indications: Pharmacology questions

Manufacturer: Wyeth Pharmaceutical Division of Wyeth Holdings LLC  
Prescribing information: [Prevnar 20](https://labeling.pfizer.com/ShowLabeling.aspx?id=15428)  
Indication pages: [Pneumococcal disease prevention in adults](https://www.evicenter.com/medical-information/prevnar-20--pneumococcal-disease-prevention-in-adults)

## Components

<a id="prevnar20-serotypes"></a>

### Which pneumococcal serotypes does Prevnar 20 contain?

> “Prevnar 20, Pneumococcal 20-valent Conjugate Vaccine is a sterile suspension of saccharides of the capsular antigens of S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, and 33F, individually linked to non-toxic diphtheria CRM197 protein.”

Source: [PREVNAR 20: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=15428#:~:text=Prevnar%2020%2C%20Pneumococcal%2020%2Dvalent%20Conjugate,to%20non%2Dtoxic%20diphtheria%20CRM197%20protein.)

> “*Prevnar 20 will only help protect against the 20 Streptococcus pneumoniae serotypes in the vaccine.<sup>1</sup>”

Source: [PREVNAR 20: PREVNAR 20® (Pneumococcal 20-valent Conjugate Vaccine) | Official HCP Site, captured 2026-11-13](https://prevnar20adult.pfizerpro.com/#:~:text=%2APrevnar%2020%20will%20only%20help,Streptococcus%20pneumoniae%20serotypes%20in%20the)

<a id="prevnar20-ingredients"></a>

### What are the ingredients in a Prevnar 20 dose?

> “Each 0.5 mL dose of the vaccine is formulated to contain approximately 2.2 μg of each of S. pneumoniae serotypes 1, 3, 4, 5, 6A, 7F, 8, 9V, 10A, 11A, 12F, 14, 15B, 18C, 19A, 19F, 22F, 23F, 33F saccharides, 4.4 μg of 6B saccharides, 51 μg CRM197 carrier protein, 100 μg polysorbate 80, 295 μg succinate buffer, 4.4 mg sodium chloride, and 125 μg aluminum as aluminum phosphate adjuvant.”

Source: [PREVNAR 20: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=15428#:~:text=Each%200.5%20mL%20dose%20of,aluminum%20as%20aluminum%20phosphate%20adjuvant.)

## Mechanism

<a id="prevnar20-mechanism"></a>

### How does Prevnar 20 work (mechanism of action)?

> “Protection against pneumococcal disease is conferred mainly by antibodies (immunoglobulin G [IgG] directed against capsular polysaccharides) and OPA killing of S. pneumoniae. Prevnar 20 induces IgG antibodies and OPA against the 20 vaccine serotypes.”

Source: [PREVNAR 20: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=15428#:~:text=Protection%20against%20pneumococcal%20disease%20is,against%20the%2020%20vaccine%20serotypes.)

> “An opsonic antibody titer or serotype-specific IgG concentration that is predictive of protection against invasive pneumococcal disease or pneumococcal pneumonia has not been established.”

Source: [PREVNAR 20: Prescribing information, captured 2026-11-13](https://labeling.pfizer.com/ShowLabeling.aspx?id=15428#:~:text=An%20opsonic%20antibody%20titer%20or,pneumonia%20has%20not%20been%20established.)

## Related pages
- [Medical information: Prevnar 20 (Pneumococcal 20-valent Conjugate Vaccine): All indications](https://www.evicenter.com/medical-information/prevnar-20)
- [Indication](https://www.evicenter.com/medical-information/prevnar-20/indication)
- [Clinical trials](https://www.evicenter.com/medical-information/prevnar-20/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/prevnar-20/safety)
- [Specific populations](https://www.evicenter.com/medical-information/prevnar-20/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/prevnar-20/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/prevnar-20/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/prevnar-20/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/prevnar-20/access-and-coverage)
